Skip to main content
Clinical Trials/NCT04593004
NCT04593004
Completed
Not Applicable

Randomized Open-Label Trial Comparing Teledermatology vs. Face-to-Face Consultation in the Follow-Up of Patients With Mild-to-Moderate Acne

Insel Gruppe AG, University Hospital Bern1 site in 1 country24 target enrollmentOctober 7, 2020
ConditionsAcne Vulgaris

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acne Vulgaris
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
24
Locations
1
Primary Endpoint
Total time spent by dermatologist after baseline
Status
Completed
Last Updated
last year

Overview

Brief Summary

Acne vulgaris is a common cutaneous inflammatory condition of sebaceous follicles that can profoundly affect patients' quality of life, especially at a young age. In this context the use of teledermatology can potentially reduce the healthcare costs associated to traditional consultations as well as the costs related to travel and loss of school/working time for the patient, with a clear benefit for the whole community. Since 2016, the Department of Dermatology at Inselspital Hospital in Bern has a portal and a smartphone app for online advice service.

Hereby the investigators propose to explicitly investigate the efficacy of this system in reducing healthcare costs as compared to traditional face-to-face consultations, in a cohort of patients with mild-to-moderate acne vulgaris.

Registry
clinicaltrials.gov
Start Date
October 7, 2020
End Date
June 20, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Given written informed consent
  • Mild-to-moderate acne as assessed by IGA scale
  • Willingness and ability to adhere the study protocol

Exclusion Criteria

  • Need for systemic therapy for acne with Isotretinoin
  • Inability to use the teledermatology system

Outcomes

Primary Outcomes

Total time spent by dermatologist after baseline

Time Frame: 4 months

Total cumulative time spent by dermatologist for face-to-face consultations or online assessments after baseline.

Secondary Outcomes

  • Number of therapies prescribed for acne(2, 4 and 6 months)
  • Patient study satisfaction(6 months)
  • Total time spent by patient after baseline(4 months)
  • Acne severity improvement(2, 4 and 6 months)
  • Patient quality of life improvement(6 months)

Study Sites (1)

Loading locations...

Similar Trials